Thousands of researchers in more than 30 countries have been collaborating and competing this year on more than 200 projects to develop a vaccine against the novel coronavirus in record time. In the most encouraging scientific advances so far, two vaccines have delivered positive news that their shots were more than 90% effective in late-stage trials. However, a number of hurdles still need to be cleared, and testing that was halted on other promising candidates highlighted the uncertainties and